Beijing Bohui Innovation Biotechnology Group (SHE:300318) has secured a license to collect blood plasma in China's Daguan County in Yunnan province.
The biotechnology company secured a plasma donor license for its Daguan Plasma Station from the Yunnan Provincial Health Commission, according to a Thursday filing with the Shenzhen bourse.
The license is valid until Sept. 10, 2026.
Price (RMB): ¥4.96, Change: ¥-0.050, Percent Change: -1.00%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.